Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based…
About Diabetes About Diabetes Diabetes mellitus is a chronic heterogeneous metabolic disease characterized by elevated blood glucose levels due to abnormalities in either insulin production or insulin action that impacts more than 37 million people inthe United Statesand over 500 million people worldwide. Type 1 diabetes, an autoimmune disorder in which the immune system destroys the pancreatic beta cells that produce insulin, accounts for 10% of diabetes cases worldwide, and type 2...
PR Newswire
19/03/2024
Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial…
"The launch of this pivotal Phase 3 trial demonstrates our commitment to harnessing the power of medical innovation to fight diseases like TB that are particularly devastating for low- and middle-income countries," said Emilio A. Emini, Ph.D., CEO of the Gates MRI. "Clinical study of the vaccine will still require years, but our incredible partners in South Africa and elsewhere who have come together for the Phase 3 study share our hope in the vaccine's potential." "The…
PR Newswire
19/03/2024
Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to…
The Maestro System is used in laparoscopy, where surgeons operate through small incisions with an internal camera and instruments. The System is powered by NVIDIA Holoscan, a powerful edge computing platform that allows real-time algorithms based on Artificial Intelligence (AI) to be deployed in the operating room for immediate benefits during surgery. The Maestro System is used in laparoscopy, where surgeons operate through small incisions with an internal camera and instruments. The System…
PR Newswire
19/03/2024
The Next Great Biotech Boom Has Arrived
This new frontier in treatment has kickstarted a multi-trillion-dollar industry geared at fixing the brain through therapy. This new frontier in treatment has kickstarted a multi-trillion-dollar industry geared at fixing the brain through therapy. Johnson and Johnson has gone all in on its fastest-growing drug for depression, SPRAVATO,which is the only FDA-approved psychedelic medicine on the market. In its Q4 2023 earnings released in January, JNJ reported a 74.1% increase in sales of...
PR Newswire
19/03/2024
Suvoda Introduces eConsent Advancements to Increase Patient Comprehension…
The latest Suvoda eConsent solution provides robust functionality to empower patients with needed "self-serve" tools to help them fully grasp complex study information, while also offering sponsors full visibility and control over consent across all study sites and patients. New features include embedded videos and FAQs, in-document discussion threads, and cross-linked glossaries. Suvoda customers identified these enhancements as critical in helping to minimize delays and, more…
PR Newswire
19/03/2024
Theriva™ Biologics to Host Conference Call and Webcast to Discuss Full Year 2023…
Individuals may participate in the live call via telephone by dialing 1-877-451-6152 (domestic) or 1-201-389-0879 (international) and using the conference ID: 13744453. Participants are asked to dial-in 15 minutes before the start of the call to register. Investors and the public can access the live and archived webcast of this call via the “News & Media” section of the company's website,https://www.therivabio.com, under “Events” or by clickinghere, up to 90 days after the call...
Nasdaq GlobeNewswire
19/03/2024
Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI…
https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spain, March19, 2024(GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI), with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements in allergy and clinical immunology. We are thrilled to extend a warm invitation to you for the upcoming EAACI Congress 2024, scheduled to...
Nasdaq GlobeNewswire
19/03/2024
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™…
The proprietary AI-Immunology™ platform brings the potential for a new era in vaccine discovery, design and development using advanced AI and machine learning technologiesAI-Immunology™ outcompetes standard vaccine target discovery approaches and holds the promise of addressing serious unmet needsWith a unique modular architecture, AI-Immunology™ is scalable and adaptable towards partner needsThe potential of AI-Immunology™ is validated by established partnerships, including an ongoing...
Nasdaq GlobeNewswire
19/03/2024
SPEVIGO® approved for expanded indications in China and the US
Generalized pustular psoriasis (GPP) is a rare, chronic, heterogenous neutrophilic inflammatory disease associated with skin and systemic symptoms, such as fever, pain, and fatigue 1,2,3,4 In China, SPEVIGO ® 's expanded approval adds the reduction of occurrences of GPP in pediatric patients aged 12 and above weighing ≥40 kg, and adults 5 The US FDA's approval expands the use of SPEVIGO ® to include the treatment of GPP in adults and pediatric patients aged 12 and above weighing ≥40 kg,...
Nasdaq GlobeNewswire
19/03/2024
Samsung Medison and Bracco Imaging Forge Path with New Diagnostic Ultrasound…
The aim of this MoU is to create synergy in research and development and market exploration by combining the techniques and marketing capabilities of Samsung Medison, one of the world's leading manufacturers of innovative premium ultrasound diagnostic equipment, and Bracco Imaging, an innovative global leader delivering end-to-end products and solutions through a comprehensive portfolio inclusive of precision diagnostic imaging modalities. The aim of this MoU is to create synergy in research...
PR Newswire
19/03/2024
Telum Therapeutics appoints Dr. Subhendu Basu as CEO
"I am truly inspired by Telum's cutting-edge science, its dynamic pipeline, and the team's accomplishments thus far," remarked Dr. Basu. "As CEO, I am eager to collaborate with the Telum scientific team and our dedicated investors to spur growth and advance Telum's investigational products into clinical trials for patient benefit." "I am truly inspired by Telum's cutting-edge science, its dynamic pipeline, and the team's accomplishments thus far," remarked Dr. Basu…
PR Newswire
19/03/2024
Leading in health technology innovation: Philips one of the top patent…
March 19, 2024 Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is one of the leading patent applicants at the European Patent Office (EPO). Building on more than 130 years of innovation, Philips' extensive global R&D programs and collaborations position the company at the forefront of health technology innovation. In 2023, Philips improved the health and well-being of 1.9 billion people with its...
Nasdaq GlobeNewswire
19/03/2024
LifeSpan Vision Ventures Invests in SENISCA
The proceeds of SENISCA's largest fundraise to date will support continued rapid company evolution and the preclinical development of the Company's senotherapeutic programmes, that target the causes of age-related disease via RNA splicing regulation, resulting in cellular reprogramming and disease modification by attenuating senescence. The proceeds of SENISCA's largest fundraise to date will support continued rapid company evolution and the preclinical development of the Company's...
PR Newswire
19/03/2024
PharmaVentures acts as the exclusive M&A advisor on the successful sale of…
Adrian Dawkes, Managing Director at PharmaVentures, said: "We are delighted to have leveraged our network and capabilities in M&A to deliver this successful outcome for Phasefocus shareholders. It is particularly pleasing to help this innovative UK technology company gain commercial validation from Bruker, a global player in the imaging, material and life science research sector." Fintan Walton, Chairman and Chief Executive at PharmaVentures added: "This transaction endorses…
PR Newswire
19/03/2024
SmartCella AB appoints Oskar Steneryd as new CFO
Niklas Prager, CEO of SmartCella, says: "It's a great pleasure to announce that Oskar is joining SmartCella. He has a stellar track record from investing in businesses in the biotech and life science space, a strong commercial focus, and a wealth of experience from financial leadership and reporting. He will be instrumental in building our Finance and Business Control function further as SmartCella is entering the next phase of expansion and market visibility. Having a CFO who combines…
PR Newswire
19/03/2024
Tetra Pharm Technologies introduces pain relieving drug in the United Kingdom
XATEPA® is a carefully formulated drug designed to provide effective relief from chronic pain as well as discomfort arising from MS spasms and nausea. The innovative sublingual spray is devised as an enabling technology to provide optimal conditions for cannabinoid uptake and efficacy. XATEPA® is a carefully formulated drug designed to provide effective relief from chronic pain as well as discomfort arising from MS spasms and nausea. The innovative sublingual spray is devised as an enabling...
PR Newswire
19/03/2024
Electrolux Group publishes restated figures for the new business area structure
From the interim report for the first quarter of 2024, Electrolux Group will be reporting in accordance with the new business area structure. From the interim report for the first quarter of 2024, Electrolux Group will be reporting in accordance with the new business area structure. The appendix to this press release contains selected restated figures by business area, by quarter and for full year 2022 and 2023. The restated financial information can also be found on the Group's website:...
PR Newswire
19/03/2024
BioArctic: Professor Lars Lannfelt, awarded Fondation Recherche Alzheimer's…
"Being able to give hope and contribute to the treatment of patients affected by Alzheimer's disease is what has driven me throughout my research life," said Professor Lars Lannfelt. "It is inspiring to see how research in this field has now begun to take quantum leaps with the development of treatments such as lecanemab which demonstrated meaningful benefits to patients in the global Phase 3 Clarity AD trial using gold standard endpoints. Coupled with the introduction of modern…
PR Newswire
19/03/2024
Implantica wins another RefluxStop™ public tender in Europe, this time in Spain…
Dr. Ruiz de Adana adds, "Our patients who had the RefluxStop™ procedure report that they no longer have episodes of gastric reflux and experienced no side effects such as dysphagia almost one year after surgery. We also see no adverse events related to RefluxStop™ so far." He goes on to say, "With sustained outcomes, RefluxStop™ has the potential to become the new standard of care for patients with severe GERD." Dr. Ruiz de Adana adds, "Our patients who had the…
PR Newswire
19/03/2024
Mendus to present NK cell program progress at the Innate Killer Summit
Press Release Stockholm, Sweden, March 19, 2024Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, announces that it will present the progress of its NK cell program at the 9th Annual Innate Killer Cell Summit, a leading conference for NK cell-based therapies.Mendus Director of Research Satwinder Kaur Singh, PhD will be expert speaker at the 9 thAnnual Innate Killer Summit held March 18-20 in San Diego, CA, USA...
Nasdaq GlobeNewswire
19/03/2024
ObsEva Announces Update on Board of Directors
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 18, 2024– ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women's health, today announced that, concurrent to the decision to wind-down the company's operations, Catarina Edfjäll, Ph.D. has decided to step down from the Board effective today.“We would like to warmly thank Catarina for her significant contribution to the company over...
Nasdaq GlobeNewswire
19/03/2024
IBA signs contract to install a Be-Efficient irradiation solution in Germany
Louvain-la-Neuve, Belgium, March 19, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial irradiation, announced today it has signed a contract for the installation of a Be-Efficient electron beam irradiation solution equipped with two Rhodotron ®accelerators in Germany. This Be-Efficient electron beam solution includes two Rhodotron ®accelerators, a Beagle® production line...
Nasdaq GlobeNewswire
19/03/2024
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory…
Dr. Fanning brings a wealth of experience in creating infectious disease pipelines by internal R&D and licensing As the CBO of AstriVax, he will lead the company's business development, including partnerships, collaborations and non dilutive funding to drive the pipeline forward and create value for future funding rounds. His initial focus will be on the company's candidate vaccine to treat chronic Hepatitis B and shape the future AstriVax vaccine pipeline.Leuven, Belgium, March...
Nasdaq GlobeNewswire
19/03/2024
Alma launches a special edition of Soprano Titanium with a breakthrough…
Engineered for efficiency and speed, the special edition of the award-winning world-leading hair removal platform leverages the benefits of three synergistic wavelengths to take the concept of speed to a whole new level with superior results: SHR, a clinically-proven, virtually painless method of laser hair removal enables effective and comfortable treatments for all skin types, 3D simultaneous lasing of the three most effective laser wavelengths for hair removal (755nm, 810nm, and 1064nm), and…
PR Newswire
19/03/2024
Altri Comunicati